Marianne Paesmans
- Prognostic and predictive factors for lung cancerBy Marianne PaesmansMarianne PaesmansInstitut Jules Bordet, Data Centre, Centre des Tumeurs de l'Université Libre de Bruxelles, Brussels, Belgium
- Late-breaking abstract: Is primary tumour standardized uptake value (SUV) an independent prognostic factor for non small cell lung cancer (NSCLC)? A meta-analysis based on individual dataBy Marianne Paesmans, Ching-Yee Oliver Wong, Edward F. Patz, Ritsuko Komaki, Susanne Eschmann, Ramaswamy Govindan, Johan Vansteenkiste, Anne-Pascale Meert, Wouter de Jong, Kotaro Higashi, Gerben Borst, Angela Van Baardwijk, Lieveke Ameye, Jean-Jacques Lafitte, Thierry Berghmans, Camilo Garcia, Patrick Flamen, Ramon Rami Porta and Jean-Paul SculierMarianne Paesmans1Data Centre, Institut Jules Bordet, Brussels, BelgiumChing-Yee Oliver Wong2Nuclear Medicine, William Beaumont School of Medicine, Royal Oak, United StatesEdward F. Patz3Radiology, Duke University Medical Center, Durham, United StatesRitsuko Komaki4Medicine, MD Anderson Cancer Center, Houston, United StatesSusanne Eschmann5Nuclear Medicine, University of Tubingen, Tubingen, GermanyRamaswamy Govindan6Medical Oncology, University School of Medicine, St-Louis, United StatesJohan Vansteenkiste7Pulmonology, University Hospital Gasthuisberg, Leuven, BelgiumAnne-Pascale Meert14Medicine and Intensive Care, Institut Jules Bordet, Brussels, BelgiumWouter de Jong8Pulmonology, University Medical Center Groningen, Groningen, NetherlandsKotaro Higashi9Radiology, Kanazawa Medical University, Ishikawa, JapanGerben Borst10Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, NetherlandsAngela Van Baardwijk11Radiation Oncology, University Hospital Maastricht, Maastricht, NetherlandsLieveke Ameye1Data Centre, Institut Jules Bordet, Brussels, BelgiumJean-Jacques Lafitte12Pulmonology, CHRU de Lille, Lille, FranceThierry Berghmans14Medicine and Intensive Care, Institut Jules Bordet, Brussels, BelgiumCamilo Garcia15Nuclear Medicine, Institut Jules Bordet, Brussels, BelgiumPatrick Flamen15Nuclear Medicine, Institut Jules Bordet, Brussels, BelgiumRamon Rami Porta13Thoracic Surgery, Hospital Universitari Mutua Terrassa, Barcelona, SpainJean-Paul Sculier1Data Centre, Institut Jules Bordet, Brussels, Belgium
- A phase III randomised trial assessing the activity of first-line ifosfamide-gemcitabine (IG), a non-platinum chemotherapy (CT), in patients with advanced non-small cell lung cancer (NSCLC)By Thierry Berghmans, Jean-Jacques Lafitte, Marianne Paesmans, Anne-Pascale Meert, Arnaud Scherpereel, Nathalie Leclercq and Jean-Paul SculierThierry Berghmans1Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumJean-Jacques Lafitte2Pneumology, CHRU Lille, Lille, FranceMarianne Paesmans3Data Centre, Institut Jules Bordet, Brussels, BelgiumAnne-Pascale Meert1Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumArnaud Scherpereel2Pneumology, CHRU Lille, Lille, FranceNathalie Leclercq1Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumJean-Paul Sculier1Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, Belgium
- The European initiative for quality management in lung cancer careBy Torsten G. Blum, Anna Rich, David Baldwin, Paul Beckett, Dirk De Ruysscher, Corinne Faivre-Finn, Mina Gaga, Fernando Gamarra, Bogdan Grigoriu, Niels C.G. Hansen, Richard Hubbard, Rudolf Maria Huber, Erik Jakobsen, Dragana Jovanovic, Assia Konsoulova, Jens Kollmeier, Gilbert Massard, John McPhelim, Anne-Pascale Meert, Robert Milroy, Marianne Paesmans, Mick Peake, Paul-Martin Putora, Arnaud Scherpereel, Nicolas Schönfeld, Helmut Sitter, Knut Skaug, Stephen Spiro, Trond-Eirik Strand, Samya Taright, Michael Thomas, Paul E. van Schil, Johan F. Vansteenkiste, Rainer Wiewrodt and Jean-Paul SculierTorsten G. BlumFor a full list of the authors affiliations see the Acknowledgements sectionAnna RichFor a full list of the authors affiliations see the Acknowledgements sectionDavid BaldwinFor a full list of the authors affiliations see the Acknowledgements sectionPaul BeckettFor a full list of the authors affiliations see the Acknowledgements sectionDirk De RuysscherFor a full list of the authors affiliations see the Acknowledgements sectionCorinne Faivre-FinnFor a full list of the authors affiliations see the Acknowledgements sectionMina GagaFor a full list of the authors affiliations see the Acknowledgements sectionFernando GamarraFor a full list of the authors affiliations see the Acknowledgements sectionBogdan GrigoriuFor a full list of the authors affiliations see the Acknowledgements sectionNiels C.G. HansenFor a full list of the authors affiliations see the Acknowledgements sectionRichard HubbardFor a full list of the authors affiliations see the Acknowledgements sectionRudolf Maria HuberFor a full list of the authors affiliations see the Acknowledgements sectionErik JakobsenFor a full list of the authors affiliations see the Acknowledgements sectionDragana JovanovicFor a full list of the authors affiliations see the Acknowledgements sectionAssia KonsoulovaFor a full list of the authors affiliations see the Acknowledgements sectionJens KollmeierFor a full list of the authors affiliations see the Acknowledgements sectionGilbert MassardFor a full list of the authors affiliations see the Acknowledgements sectionJohn McPhelimFor a full list of the authors affiliations see the Acknowledgements sectionAnne-Pascale MeertFor a full list of the authors affiliations see the Acknowledgements sectionRobert MilroyFor a full list of the authors affiliations see the Acknowledgements sectionMarianne PaesmansFor a full list of the authors affiliations see the Acknowledgements sectionMick PeakeFor a full list of the authors affiliations see the Acknowledgements sectionPaul-Martin PutoraFor a full list of the authors affiliations see the Acknowledgements sectionArnaud ScherpereelFor a full list of the authors affiliations see the Acknowledgements sectionNicolas SchönfeldFor a full list of the authors affiliations see the Acknowledgements sectionHelmut SitterFor a full list of the authors affiliations see the Acknowledgements sectionKnut SkaugFor a full list of the authors affiliations see the Acknowledgements sectionStephen SpiroFor a full list of the authors affiliations see the Acknowledgements sectionTrond-Eirik StrandFor a full list of the authors affiliations see the Acknowledgements sectionSamya TarightFor a full list of the authors affiliations see the Acknowledgements sectionMichael ThomasFor a full list of the authors affiliations see the Acknowledgements sectionPaul E. van SchilFor a full list of the authors affiliations see the Acknowledgements sectionJohan F. VansteenkisteFor a full list of the authors affiliations see the Acknowledgements sectionRainer WiewrodtFor a full list of the authors affiliations see the Acknowledgements sectionJean-Paul SculierFor a full list of the authors affiliations see the Acknowledgements section
- A mRNA signature predicts outcome of patients (pts) with advanced non small cell lung cancer (NSCLC) treated with cisplatin (C) and vinorelbine (V): A ELCWP prospective studyBy Thierry Berghmans, Luc Willems, Marianne Paesmans, Lieveke Ameye, Jean-Jacques Lafitte, Anne-Pascale Meert, Arnaud Scherpereel, Alexis Cortot, Céline Mascaux, Ingrid CsToth, Tiffany Dernies, Nathalie Leclercq and Jean-Paul SculierThierry Berghmans1Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumLuc Willems2Molecular and Cellular Biology Laboratory, Gemboux Agro-Bio Tech, Gembloux, BelgiumMarianne Paesmans3Data Centre, Institut Jules Bordet, Brussels, BelgiumLieveke Ameye3Data Centre, Institut Jules Bordet, Brussels, BelgiumJean-Jacques Lafitte4Pneumology, CHU Lille, Lille, FranceAnne-Pascale Meert1Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumArnaud Scherpereel4Pneumology, CHU Lille, Lille, FranceAlexis Cortot4Pneumology, CHU Lille, Lille, FranceCéline Mascaux1Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumIngrid CsToth1Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumTiffany Dernies1Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumNathalie Leclercq1Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumJean-Paul Sculier1Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Brussels, Belgium
- Histology as a potential clinical predictor of outcome in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine and mitomycin (VM) combination chemotherapyBy Thomas Wibmer, Thierry Berghmans, Cornelia Kropf, Jean-Jacques Lafitte, Kathrin M. Stoiber, Marianne Paesmans, Stefan Ruediger, Arnaud Scherpereel, Ioanna Blanta, Wolfgang Rottbauer, Jean-Paul Sculier and Christian SchumannThomas Wibmer1Department of Internal Medicine II, University of Ulm Medical Center, Ulm, GermanyThierry Berghmans2Department of Intensive Care Unit and Thoracic Oncology, Université libre de Bruxelles, Brussels, BelgiumCornelia Kropf1Department of Internal Medicine II, University of Ulm Medical Center, Ulm, GermanyJean-Jacques Lafitte3Department of Pneumology, CHU de Lille, Lille, FranceKathrin M. Stoiber1Department of Internal Medicine II, University of Ulm Medical Center, Ulm, GermanyMarianne Paesmans4Data Center, Institut Jules Bordet, Université libre de Bruxelles, Brussels, BelgiumStefan Ruediger1Department of Internal Medicine II, University of Ulm Medical Center, Ulm, GermanyArnaud Scherpereel3Department of Pneumology, CHU de Lille, Lille, FranceIoanna Blanta1Department of Internal Medicine II, University of Ulm Medical Center, Ulm, GermanyWolfgang Rottbauer1Department of Internal Medicine II, University of Ulm Medical Center, Ulm, GermanyJean-Paul Sculier2Department of Intensive Care Unit and Thoracic Oncology, Université libre de Bruxelles, Brussels, BelgiumChristian Schumann1Department of Internal Medicine II, University of Ulm Medical Center, Ulm, Germany
- Ifosfamide (IFO) is a valuable alternative to cisplatin (CDDP) for first-line chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC): A meta-analysisBy Thierry Berghmans, Marianne Paesmans, Anne-Pascale Meert, Marcello Tiseo and Jean-Paul SculierThierry Berghmans1Department of Oncological Intensive Care and Emergencies & Clinic of Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumMarianne Paesmans2Data Centre, Institut Jules Bordet, Brussels, BelgiumAnne-Pascale Meert1Department of Oncological Intensive Care and Emergencies & Clinic of Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumMarcello Tiseo3Medical Oncology, University Hospital of Parma, Parma, ItalyJean-Paul Sculier1Department of Oncological Intensive Care and Emergencies & Clinic of Thoracic Oncology, Institut Jules Bordet, Brussels, Belgium
- The European initiative for quality management in lung cancer careBy Torsten G. Blum, Anna Rich, David Baldwin, Paul Beckett, Dirk De Ruysscher, Corinne Faivre-Finn, Mina Gaga, Fernando Gamarra, Bogdan Grigoriu, Niels C.G. Hansen, Richard Hubbard, Rudolf Maria Huber, Erik Jakobsen, Dragana Jovanovic, Assia Konsoulova, Jens Kollmeier, Gilbert Massard, John McPhelim, Anne-Pascale Meert, Robert Milroy, Marianne Paesmans, Mick Peake, Paul-Martin Putora, Arnaud Scherpereel, Nicolas Schönfeld, Helmut Sitter, Knut Skaug, Stephen Spiro, Trond-Eirik Strand, Samya Taright, Michael Thomas, Paul E. van Schil, Johan F. Vansteenkiste, Rainer Wiewrodt and Jean-Paul SculierArticle | Published in 2014 in European Respiratory JournalTorsten G. BlumFor a full list of the authors affiliations see the Acknowledgements sectionAnna RichFor a full list of the authors affiliations see the Acknowledgements sectionDavid BaldwinFor a full list of the authors affiliations see the Acknowledgements sectionPaul BeckettFor a full list of the authors affiliations see the Acknowledgements sectionDirk De RuysscherFor a full list of the authors affiliations see the Acknowledgements sectionCorinne Faivre-FinnFor a full list of the authors affiliations see the Acknowledgements sectionMina GagaFor a full list of the authors affiliations see the Acknowledgements sectionFernando GamarraFor a full list of the authors affiliations see the Acknowledgements sectionBogdan GrigoriuFor a full list of the authors affiliations see the Acknowledgements sectionNiels C.G. HansenFor a full list of the authors affiliations see the Acknowledgements sectionRichard HubbardFor a full list of the authors affiliations see the Acknowledgements sectionRudolf Maria HuberFor a full list of the authors affiliations see the Acknowledgements sectionErik JakobsenFor a full list of the authors affiliations see the Acknowledgements sectionDragana JovanovicFor a full list of the authors affiliations see the Acknowledgements sectionAssia KonsoulovaFor a full list of the authors affiliations see the Acknowledgements sectionJens KollmeierFor a full list of the authors affiliations see the Acknowledgements sectionGilbert MassardFor a full list of the authors affiliations see the Acknowledgements sectionJohn McPhelimFor a full list of the authors affiliations see the Acknowledgements sectionAnne-Pascale MeertFor a full list of the authors affiliations see the Acknowledgements sectionRobert MilroyFor a full list of the authors affiliations see the Acknowledgements sectionMarianne PaesmansFor a full list of the authors affiliations see the Acknowledgements sectionMick PeakeFor a full list of the authors affiliations see the Acknowledgements sectionPaul-Martin PutoraFor a full list of the authors affiliations see the Acknowledgements sectionArnaud ScherpereelFor a full list of the authors affiliations see the Acknowledgements sectionNicolas SchönfeldFor a full list of the authors affiliations see the Acknowledgements sectionHelmut SitterFor a full list of the authors affiliations see the Acknowledgements sectionKnut SkaugFor a full list of the authors affiliations see the Acknowledgements sectionStephen SpiroFor a full list of the authors affiliations see the Acknowledgements sectionTrond-Eirik StrandFor a full list of the authors affiliations see the Acknowledgements sectionSamya TarightFor a full list of the authors affiliations see the Acknowledgements sectionMichael ThomasFor a full list of the authors affiliations see the Acknowledgements sectionPaul E. van SchilFor a full list of the authors affiliations see the Acknowledgements sectionJohan F. VansteenkisteFor a full list of the authors affiliations see the Acknowledgements sectionRainer WiewrodtFor a full list of the authors affiliations see the Acknowledgements sectionJean-Paul SculierFor a full list of the authors affiliations see the Acknowledgements section
- Systematic qualitative review of randomised trials conducted in NSCLC with a noninferiority or equivalence designBy Marianne Paesmans, Bogdan Grigoriu, Sebahat Ocak, Martine Roelandts, Jean-Jacques Lafitte, Stéphane Holbrechts, Thierry Berghmans, Anne-Pascale Meert, Luigi Moretti, Sophie Danyi, Françoise Pasleau, Lieveke Ameye, Alain Van Meerhaeghe and Jean-Paul SculierArticle | Published in 2014 in European Respiratory JournalMarianne Paesmans1Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumBogdan Grigoriu2Thoracic Oncology Dept, Regional Institute of Oncology Iasi, University of Medicine and Pharmacy, “Gr. T. Popa”, Iasi, RomaniaSebahat Ocak3Pneumology Dept, CHU Mont-Godinne, Université Catholique de Louvain, Yvoir, BelgiumMartine Roelandts4Radiotherapy Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumJean-Jacques Lafitte5Pneumology Dept, CHU Lille, University of Lille 2, Lille, FranceStéphane Holbrechts6Medical Oncology Dept, CHU Ambroise Paré, Mons, BelgiumThierry Berghmans7Thoracic Oncology and Intensive Care Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumAnne-Pascale Meert7Thoracic Oncology and Intensive Care Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumLuigi Moretti4Radiotherapy Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumSophie Danyi8Library of Life Sciences, Université de Liège, Liège, BelgiumFrançoise Pasleau8Library of Life Sciences, Université de Liège, Liège, BelgiumLieveke Ameye1Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumAlain Van Meerhaeghe9Pneumology Department, CHU Charleroi, Charleroi, BelgiumJean-Paul Sculier7Thoracic Oncology and Intensive Care Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- Muldisciplinary conference (MDC), oncological program (OP) and practice guidelines (GL): The experience of the lung cancer (LC) clinic of a cancer hospitalBy Jean-Paul Sculier, Leclercq Nathalie, Anne-Pascale Meert, Ingrid C.S. Toth, Marianne Paesmans and Thierry BerghmansJean-Paul Sculier1ICU and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumLeclercq Nathalie1ICU and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumAnne-Pascale Meert1ICU and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumIngrid C.S. Toth1ICU and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumMarianne Paesmans2Data Center, Institut Jules Bordet, Brussels, BelgiumThierry Berghmans1ICU and Thoracic Oncology, Institut Jules Bordet, Brussels, Belgium
- Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence designBy Marianne Paesmans, Bogdan Grigoriu, Sebahat Ocak, Martine Roelandts, Jean-Jacques Lafitte, Stéphane Holbrechts, Thierry Berghmans, Anne-Pascale Meert, Luigi Moretti, Sophie Danyi, Françoise Pasleau, Lieveke Ameye, Alain Van Meerhaeghe and Jean-Paul SculierMarianne Paesmans1Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumBogdan Grigoriu2Thoracic Oncology Dept, Regional Institute of Oncology Iasi, University of Medicine and Pharmacy, “Gr. T. Popa”, Iasi, RomaniaSebahat Ocak3Pneumology Dept, CHU Mont-Godinne, Université Catholique de Louvain, Yvoir, BelgiumMartine Roelandts4Radiotherapy Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumJean-Jacques Lafitte5Pneumology Dept, CHU Lille, University of Lille 2, Lille, FranceStéphane Holbrechts6Medical Oncology Dept, CHU Ambroise Paré, Mons, BelgiumThierry Berghmans7Thoracic Oncology and Intensive Care Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumAnne-Pascale Meert7Thoracic Oncology and Intensive Care Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumLuigi Moretti4Radiotherapy Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumSophie Danyi8Library of Life Sciences, Université de Liège, Liège, BelgiumFrançoise Pasleau8Library of Life Sciences, Université de Liège, Liège, BelgiumLieveke Ameye1Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumAlain Van Meerhaeghe9Pneumology Department, CHU Charleroi, Charleroi, BelgiumJean-Paul Sculier7Thoracic Oncology and Intensive Care Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual dataBy Marianne Paesmans, Camilo Garcia, Ching-Yee Oliver Wong, Edward F. Patz, Ritsuko Komaki, Susanne Eschmann, Ramaswamy Govindan, Johan Vansteenkiste, Anne-Pascale Meert, Wouter K. de Jong, Nasser Khaled Altorki, Kotaro Higashi, Angela Van Baardwijk, Gerben R. Borst, Lieveke Ameye, Jean-Jacques Lafitte, Thierry Berghmans, Patrick Flamen, Ramon Rami-Porta and Jean-Paul SculierArticle | Published in 2015 in European Respiratory JournalMarianne Paesmans1Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium18Both authors contributed equallyCamilo Garcia2Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium18Both authors contributed equallyChing-Yee Oliver Wong3Diagnostic Radiology and Molecular Imaging, Oakland University William Beaumont School of Medicine, William Beaumont Hospital, Royal Oak, MI, USAEdward F. Patz Jr4Radiology, Duke University Medical Center, Durham, NC, USARitsuko Komaki5The University of Texas MD Anderson Cancer Center, Houston, TX, USASusanne Eschmann6Nuclear Medicine, University of Tubingen, Tubingen, GermanyRamaswamy Govindan7Division of Medical Oncology, Washington University School of Medicine, St. Louis, MI, USAJohan Vansteenkiste8Pneumology, Respiratory Oncology Unit, University Hospitals KU Leuven, Leuven, BelgiumAnne-Pascale Meert9Intensive Care and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumWouter K. de Jong10Pneumology, Ziekenhuis Gelderse Vallei, Ede, The NetherlandsNasser Khaled Altorki11Thoracic Surgery, Weill Cornell Medical College, New York, NY, USAKotaro Higashi12Radiology, Asanogawa General Hospital, Ishikawa, JapanAngela Van Baardwijk13Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The NetherlandsGerben R. Borst14Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsLieveke Ameye1Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumJean-Jacques Lafitte15Pulmonary and Thoracic Oncology, CHRU de Lille, Lille, FranceThierry Berghmans9Intensive Care and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumPatrick Flamen2Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumRamon Rami-Porta17Thoracic Surgery, Hospital Universitari Mutua Terrassa and CIBERES Lung Cancer Group, Terrassa, SpainJean-Paul Sculier9Intensive Care and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?By Marianne PaesmansMarianne PaesmansData Centre, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Brussels, Belgium
- A phase III trial comparing concomitant radiochemotherapy (RT-CT) with cisplatin (P) and docetaxel (D) as induction versus consolidation in patients with locally advanced unresectable non-small cell lung cancer (NSCLC). An ELCWP studyBy Thierry Berghmans, Jean-Jacques Lafitte, Marianne Paesmans, Anne-Pascale Meert, Arnaud Scherpereel, Oswald Van Cutsem, Benoit Colinet, Paul Van Houtte, Martine Roelandts, Nathalie Leclercq and Jean-Paul SculierThierry Berghmans1Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumJean-Jacques Lafitte2Pneumology, CHU Lille, Lille, FranceMarianne Paesmans3Data Centre, Institut Jules Bordet, Brussels, BelgiumAnne-Pascale Meert1Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumArnaud Scherpereel2Pneumology, CHU Lille, Lille, FranceOswald Van Cutsem4Pneumology, Clinique Saint-Luc, Bouge, BelgiumBenoit Colinet5Pneumology, Hôpital Saint-Joseph, Gilly, BelgiumPaul Van Houtte6Radiotherapy, Institut Jules Bordet, Brussels, BelgiumMartine Roelandts6Radiotherapy, Institut Jules Bordet, Brussels, BelgiumNathalie Leclercq1Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, BelgiumJean-Paul Sculier1Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, Belgium
- Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual dataBy Marianne Paesmans, Camilo Garcia, Ching-Yee Oliver Wong, Edward F. Patz Jr, Ritsuko Komaki, Susanne Eschmann, Ramaswamy Govindan, Johan Vansteenkiste, Anne-Pascale Meert, Wouter K. de Jong, Nasser Khaled Altorki, Kotaro Higashi, Angela Van Baardwijk, Gerben R. Borst, Lieveke Ameye, Jean-Jacques Lafitte, Thierry Berghmans, Patrick Flamen, Ramon Rami-Porta and Jean-Paul SculierMarianne Paesmans1Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium18Both authors contributed equallyCamilo Garcia2Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium18Both authors contributed equallyChing-Yee Oliver Wong3Diagnostic Radiology and Molecular Imaging, Oakland University William Beaumont School of Medicine, William Beaumont Hospital, Royal Oak, MI, USAEdward F. Patz Jr4Radiology, Duke University Medical Center, Durham, NC, USARitsuko Komaki5The University of Texas MD Anderson Cancer Center, Houston, TX, USASusanne Eschmann6Nuclear Medicine, University of Tubingen, Tubingen, GermanyRamaswamy Govindan7Division of Medical Oncology, Washington University School of Medicine, St. Louis, MI, USAJohan Vansteenkiste8Pneumology, Respiratory Oncology Unit, University Hospitals KU Leuven, Leuven, BelgiumAnne-Pascale Meert9Intensive Care and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumWouter K. de Jong10Pneumology, Ziekenhuis Gelderse Vallei, Ede, The NetherlandsNasser Khaled Altorki11Thoracic Surgery, Weill Cornell Medical College, New York, NY, USAKotaro Higashi12Radiology, Asanogawa General Hospital, Ishikawa, JapanAngela Van Baardwijk13Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The NetherlandsGerben R. Borst14Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsLieveke Ameye1Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumJean-Jacques Lafitte15Pulmonary and Thoracic Oncology, CHRU de Lille, Lille, FranceThierry Berghmans9Intensive Care and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumPatrick Flamen2Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumRamon Rami-Porta17Thoracic Surgery, Hospital Universitari Mutua Terrassa and CIBERES Lung Cancer Group, Terrassa, SpainJean-Paul Sculier9Intensive Care and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.